Bioceres Crop Solutions vs FutureFuel
BIOX and FF side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BIOX and FF compare
FutureFuel grew revenue faster over the last twelve months (71.2% versus −17.7% for Bioceres Crop Solutions).
FutureFuel pays a dividend yielding 5.0%; Bioceres Crop Solutions does not pay one.
FutureFuel scores higher on the StockData Score (13 against 1 for Bioceres Crop Solutions), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BIOX | FF |
|---|---|---|
| Size and price | ||
| Market cap | – | $123M |
| Share price | $0.233 | $2.81 |
| Change, 1 year | −86.6% | −27.6% |
| Change, 5 years | −98.5% | −65.9% |
| Beta (5Y) | 0.76 | 0.83 |
| Employees | 562 | 493 |
| StockData Score | ||
| Total score | 1 | 13 (better) |
| Valuation score | 0 | 3 (better) |
| Growth score | 0 | 2 (better) |
| Performance score | 0 | 1 (better) |
| Health score | 1 | 4 (better) |
| Dividend score | 0 | 3 (better) |
| Valuation | ||
| P/S | – | 0.5× |
| P/B | – | 0.9× |
| FCF yield | – | −47.1% |
| Fair value | – | $4.96 |
| Margin of safety | – | 43.3% |
| Growth | ||
| Revenue growth (TTM) | −17.7% | 71.2% (better) |
| Revenue growth, 5Y average | 2.6% (better) | −14.1% |
| Profitability | ||
| Gross margin | 34.9% (better) | −5.0% |
| Operating margin | −9.8% (better) | −11.5% |
| Net margin | – | −10.9% |
| FCF margin | 27.3% (better) | −24.7% |
| Return on equity | – | −16.2% |
| Return on invested capital | −7.4% (better) | −20.4% |
| Financial health | ||
| Debt / equity | 10.01 (better) | 0.00 |
| Interest coverage | −0.6× (better) | −500.7× |
| Current ratio | 0.80 | 3.87 (better) |
| Altman Z-score | – | 2.01 |
| Piotroski F-score | – | 3 |
| Dividends and buybacks | ||
| Dividend yield | – | 5.0% |
| Shareholder yield | – | 5.0% |
| Ownership | ||
| Held by institutions | 13.2% | 38.6% |
| Held by insiders | 73.3% | 40.5% |
| Insider net buying, 12 months | – | $42.8K |
| Short interest, % of float | 2.7% | 6.8% |
Go deeper
- BIOX stock overview
- BIOX income statement
- BIOX valuation and score
- FF stock overview
- FF income statement
- FF valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.